Lv3
210 积分 2022-03-02 加入
Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
9小时前
待确认
Efficacy and quality‐of‐life improvements with fremanezumab treatment in patients with difficult‐to‐treat migraine with associated neurological dysfunction
9小时前
已完结
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
12小时前
已完结
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
12小时前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
3个月前
已完结
皖公网安备34019202002308
